查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1287461

代谢组学市场：2023-2028年全球行业趋势、份额、规模、增长、机会和预测

Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

市场概述：

全球代谢组学市场规模在2022年达到24亿美元。展望未来，IMARC集团预计到2028年，市场规模将达到47亿美元，在2023-2028年期间表现出11.55%的增长率（CAGR）。

代谢组学是指对细胞、生物液体、组织和生物体内的代谢物或小分子的大规模研究。它是一种分析方法，用于在各种生物样本和系统中进行系统的代谢分析和指纹识别。它包括各种检测技术，如核磁共振（NMR）光谱和质谱（MS），同时还有分离技术，如气相色谱法。这些技术通常用于代谢组研究、毒理学测试和开发个性化药物。它们还提供了对健康的评估和对医疗疾病（如心血管和神经系统疾病和癌症）的原因和治疗的洞察。

癌症和其他慢性病发病率的增加是推动市场增长的关键因素之一。此外，制药业的大幅增长，以及对个性化药物需求的上升，也为市场增长提供了动力。代谢组学促进了对基因和蛋白质的研究，以及有助于发现和开发药物和管理疾病进展的生物标志物的发展。此外，代谢组学与机器学习（ML）的整合也有利于市场的增长。机器学习有助于准确解释使用核磁共振和质谱技术产生的数据，并使复杂、重复和耗时的过程自动化。先进的ML软件还提供全面的分析和可视化功能，以表示大量的数据。其他因素，包括快速城市化和生物技术领域广泛的研究和开发（R&D）活动，预计将在未来几年推动市场发展。

本报告中回答的关键问题：

  • 迄今为止，全球代谢组学市场的表现如何，未来几年将如何表现？
  • 主要的区域市场是什么？
  • COVID-19对全球代谢组学市场的影响是什么？
  • 基于产品的市场细分是什么？
  • 基于适应症的市场细分是什么？
  • 基于应用的市场细分是什么？
  • 该行业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球代谢组学市场的结构是什么，谁是主要参与者？
  • 该行业的竞争程度如何？

目录

第一章：前言

第二章：范围和方法

  • 研究的目标
  • 利益相关者
  • 数据来源
    • 主要来源
    • 二级来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球代谢组学市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：按产品分類的市场

  • 代谢组学仪器
    • 市场趋势
    • 市场预测
  • 代谢组学生物信息学工具和服务
    • 市场趋势
    • 市场预测

第7章 ：按适应症分類的市场

  • 癌症
    • 市场趋势
    • 市场预测
  • 心血管疾病
    • 市场趋势
    • 市场预测
  • 神经系统疾病
    • 市场趋势
    • 市场预测
  • 先天性代谢错误
    • 市场趋势
    • 市场预测
  • 其他疾病
    • 市场趋势
    • 市场预测

第8章：按应用分類的市场

  • 生物标志物和药物发现
    • 市场趋势
    • 市场预测
  • 毒理学
    • 市场趋势
    • 市场预测
  • 营养基因组学
    • 市场趋势
    • 市场预测
  • 个体化医疗
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第九章：按地区分類的市场

  • 北美洲
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场预测
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场预测
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场预测
    • 韩国
      • 市场趋势
      • 市场预测
    • 澳大利亚
      • 市场趋势
      • 市场预测
    • 印尼
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场预测
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场预测
    • 西班牙
      • 市场趋势
      • 市场预测
    • 俄罗斯
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场预测
    • 墨西哥
      • 市场趋势
      • 市场预测
    • 其他国家
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家分類的市场
    • 市场预测

第十章：SWOT分析

  • 概述
  • 优势
  • 劣势
  • 机会
  • 威胁

第十一章 ：价值链分析

第十二章 ：波特斯五力分析

  • 概述
  • 买方的讨价还价能力
  • 供应商的讨价还价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第13章 ：竞争格局

  • 市场结构
  • 主要竞争者
  • 主要竞争者简介
    • Agilent Technologies Inc.
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Danaher Corporation
    • Human Metabolome Technologies Inc.
    • Metabolon Inc.
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR1623A162_Report

Market Overview:

The global metabolomics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.55% during 2023-2028.

Metabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems. It consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.

The increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression. Additionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global metabolomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and application.

Breakup by Product:

  • Metabolomics Instruments
  • Metabolomics Bioinformatics Tools and Services

Breakup by Indication:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

Breakup by Application:

  • Biomarker and Drug Discovery
  • Toxicology
  • Nutrigenomics
  • Personalized Medicine
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Human Metabolome Technologies Inc., Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report:

  • How has the global metabolomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global metabolomics market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global metabolomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Metabolomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Metabolomics Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metabolomics Bioinformatics Tools and Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Inborn Errors of Metabolism
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Biomarker and Drug Discovery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Toxicology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nutrigenomics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Personalized Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biocrates Life Sciences AG
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Bio-Rad Laboratories Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bruker Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Human Metabolome Technologies Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Metabolon Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Shimadzu Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Thermo Fisher Scientific Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Waters Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
  • Figure 2: Global: Metabolomics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2022
  • Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2022
  • Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Metabolomics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Metabolomics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Metabolomics (Bioinformatics Tools and Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Metabolomics (Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Global: Metabolomics Industry: SWOT Analysis
  • Figure 81: Global: Metabolomics Industry: Value Chain Analysis
  • Figure 82: Global: Metabolomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Metabolomics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Metabolomics Market: Competitive Structure
  • Table 7: Global: Metabolomics Market: Key Players